Drug Profile
Research programme: anti-inflammatory antibodies - MorphoSys
Alternative Names: MOR 104Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator MorphoSys
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Germany (Parenteral)
- 29 Jul 2009 Early research in Inflammation in Germany (Parenteral)